• Mashup Score: 0
    icn_podcast - 8 month(s) ago

    By: Charles C. Wykoff, MD, PhD (Chair); Mrinali Gupta, MD; Geeta A. Lalwani, MD; Anton Orlin, MD; Jayanth Sridhar, MD This continuing medical education (CME) activity captures content from a roundtable discussion. This supplement summarizes a discussion on understanding clinical trial data on emerging and potential therapies for geographic atrophy and communicating with patients. This certified CME activity is designed for retina specialists. Expiration Date: Tuesday, April 30, 2024 Release Date: March

    Tweet Tweets with this article
    • Drs. Wykoff, Gupta, Lalwani, Orlin, & Sridhar invite you to check out this new #CME supplement, and earn #AMAcredit, at your convenience. Geographic Atrophy Management: The Role of Complement Modulation-Based Therapies. View here: https://t.co/sZdOPKi8Vs https://t.co/aAOsr2AfHA

  • Mashup Score: 0

    Learning Objectives Upon completion of this activity, the participant should be able to: Review updates in the classification for dry age-related macular degeneration, in particular the significance of incomplete retinal pigment epithelial and outer retinal atrophy (iRORA) and complete retinal pigment epithelial…

    Tweet Tweets with this article
    • Check out this new #CME Supplement that summarizes a discussion on understanding clinical trial data on emerging & potential therapies for geographic atrophy & communicating with patients. View here: https://t.co/sZdOPKi8Vs https://t.co/3RFXv5i3DS